Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference

Rhea-AI Summary

Ardelyx, Inc. (Nasdaq: ARDX) to present at H.C. Wainwright 2nd Annual Kidney Conference. Mike Raab, president and CEO, to speak on July 25, 2023, at 2:00 P.M. Eastern Time. Webcast available on Ardelyx website.

WALTHAM, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president and chief executive officer of Ardelyx, will present on behalf of the company at the virtual H.C. Wainwright 2nd Annual Kidney Conference on Tuesday, July 25, 2023 at 2:00 P.M. Eastern Time.

To access the live webcast of the presentation, please visit the Events and Presentations page within the Ardelyx website at https://ir.ardelyx.com/events-and-presentations. A replay of the presentation will be available on the Ardelyx website for 30 days following the event.

About Ardelyx, Inc.
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx’s first approved product, IBSRELA^® (tenapanor) is available in the United States and Canada. Ardelyx is developing XPHOZAH^® (tenapanor), a novel product candidate for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis, which has completed three successful Phase 3 trials. Ardelyx has a Phase 2 potassium lowering compound, RDX013, for the potential treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease and an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD. Ardelyx has established agreements with Kyowa Kirin in Japan, Fosun Pharma in China and Knight Therapeutics in Canada for the development and commercialization of tenapanor in their respective territories. For more information, please visit https://ardelyx.com/ and connect with us on Twitter, LinkedIn and Facebook.

Investor and Media Contacts:
Caitlin Lowie
clowie@ardelyx.com

Kimia Keshtbod
kkeshtbod@ardelyx.com

FAQ

What is the event Ardelyx, Inc. will be presenting at?

Ardelyx, Inc. will be presenting at the virtual H.C. Wainwright 2nd Annual Kidney Conference.

Who will be speaking on behalf of Ardelyx, Inc. at the conference?

Mike Raab, the president and chief executive officer of Ardelyx, will be presenting on behalf of the company.

Where can the live webcast of the presentation be accessed?

The live webcast of the presentation can be accessed on the Events and Presentations page within the Ardelyx website at https://ir.ardelyx.com/events-and-presentations.

Will a replay of the presentation be available?

Yes, a replay of the presentation will be available on the Ardelyx website for 30 days following the event.